Delavirdine mesilate or mesylate

This classification denotes a reverse transcriptase inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 421105KRQE. European Medicines Agency schedules Delavirdine mesilate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01575MIG. Delavirdine mesylate generally arises in the molecular formula C22H28N6O3S.CH4O3S. The term 'delavirdine mesylate' is a Japanese Accepted Name designation. Most nations, for tariff and trade purposes, schedule delavirdine mesylate under HS 29350090 and SITC 51580. As of Q4 2014, DELAVIRDINE MESYLATE remains US FDA's Preferred Term for this commodity. Delavirdine mesylate bears US NLM identifiers UMLS ID C0543492 and NCI Concept Code C28974. SMILES: CC(C)NC1CCCNC1N2CCN(CC2)C(=O)C3CC4CC(CCC4[NH]3)NS(=O)(=O)C.CS(=O)(=O)O.